Two-Drug HIV Regimen Gains FDA Approval Phase 3 trials showed noninferior viral suppression vs standard three-drug therapy with similar safety outcomes By Kathryn Wighton April 21, 2026 2 min Conexiant Share Summary Listen Insight Report Clinical Scorecard Quiz Poll Top Institutions